These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32460818)

  • 1. Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis (the EASI-SWITCH trial): study protocol for a randomised controlled trial.
    Forde C; McMullan R; Clarke M; Wilson RH; Plummer R; Grayson M; McDowell C; Agus A; Doran A; McAuley DF; Thomas AL; Barnes RA; Adams R; Chau I; Coyle V
    Trials; 2020 May; 21(1):431. PubMed ID: 32460818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCT.
    Coyle V; Forde C; Adams R; Agus A; Barnes R; Chau I; Clarke M; Doran A; Grayson M; McAuley D; McDowell C; Phair G; Plummer R; Storey D; Thomas A; Wilson R; McMullan R
    Health Technol Assess; 2024 Mar; 28(14):1-101. PubMed ID: 38512064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT.
    Scarborough M; Li HK; Rombach I; Zambellas R; Walker AS; McNally M; Atkins B; Kümin M; Lipsky BA; Hughes H; Bose D; Warren S; Mack D; Folb J; Moore E; Jenkins N; Hopkins S; Seaton RA; Hemsley C; Sandoe J; Aggarwal I; Ellis S; Sutherland R; Geue C; McMeekin N; Scarborough C; Paul J; Cooke G; Bostock J; Khatamzas E; Wong N; Brent A; Lomas J; Matthews P; Wangrangsimakul T; Gundle R; Rogers M; Taylor A; Thwaites GE; Bejon P
    Health Technol Assess; 2019 Aug; 23(38):1-92. PubMed ID: 31373271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early switch to oral antibiotic therapy in patients with low-risk neutropenic sepsis (EASI-SWITCH): a randomized non-inferiority trial.
    Coyle V; Forde C; McAuley DF; Wilson RH; Clarke M; Plummer R; Grayson M; McDowell C; Agus A; Doran A; Thomas AL; Barnes RA; Adams R; Chau I; Storey D; McMullan R;
    Clin Microbiol Infect; 2024 Jan; 30(1):92-99. PubMed ID: 37517522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-centre, pragmatic, three-arm, individually randomised, non-inferiority, open trial to compare immediate orally administered, immediate topically administered or delayed orally administered antibiotics for acute otitis media with discharge in children: The Runny Ear Study (REST): study protocol.
    Curtis K; Moore M; Cabral C; Curcin V; Horwood J; Morris R; Prasad V; Schilder A; Turner N; Wilkes S; Hay AD; Taylor J
    Trials; 2020 Jun; 21(1):463. PubMed ID: 32493407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous co-amoxiclav to prevent infection after operative vaginal delivery: the ANODE RCT.
    Knight M; Chiocchia V; Partlett C; Rivero-Arias O; Hua X; Bowler U; Gray J; Gray S; Hinshaw K; Khunda A; Moore P; Mottram L; Owino N; Pasupathy D; Sanders J; Sultan AH; Thakar R; Tuffnell D; Linsell L; Juszczak E
    Health Technol Assess; 2019 Oct; 23(54):1-54. PubMed ID: 31590702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study.
    Innes HE; Smith DB; O'Reilly SM; Clark PI; Kelly V; Marshall E
    Br J Cancer; 2003 Jul; 89(1):43-9. PubMed ID: 12838298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early oral stepdown antibiotic therapy versus continuing intravenous therapy for uncomplicated Gram-negative bacteraemia (the INVEST trial): study protocol for a multicentre, randomised controlled, open-label, phase III, non-inferiority trial.
    Lee IR; Tong SYC; Davis JS; Paterson DL; Syed-Omar SF; Peck KR; Chung DR; Cooke GS; Libau EA; Rahman SBA; Gandhi MP; Shi L; Zheng S; Chaung J; Tan SY; Kalimuddin S; Archuleta S; Lye DC
    Trials; 2022 Jul; 23(1):572. PubMed ID: 35854360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST).
    Ten Doesschate T; van Mens SP; van Nieuwkoop C; Geerlings SE; Hoepelman AIM; Bonten MJM
    BMC Infect Dis; 2018 Dec; 18(1):626. PubMed ID: 30518334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of switching from intravenous to oral antibiotics (amoxicillin-clavulanic acid) versus a full course of intravenous antibiotics in neonates with probable bacterial infection (RAIN): a multicentre, randomised, open-label, non-inferiority trial.
    Keij FM; Kornelisse RF; Hartwig NG; van der Sluijs-Bens J; van Beek RHT; van Driel A; van Rooij LGM; van Dalen-Vink I; Driessen GJA; Kenter S; von Lindern JS; Eijkemans M; Stam-Stigter GM; Qi H; van den Berg MM; Baartmans MGA; van der Meer-Kappelle LH; Meijssen CB; Norbruis OF; Heidema J; van Rossem MC; den Butter PCP; Allegaert K; Reiss IKM; Tramper-Stranders GA
    Lancet Child Adolesc Health; 2022 Nov; 6(11):799-809. PubMed ID: 36088952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectious diseases group trial XV.
    Kern WV; Marchetti O; Drgona L; Akan H; Aoun M; Akova M; de Bock R; Paesmans M; Viscoli C; Calandra T
    J Clin Oncol; 2013 Mar; 31(9):1149-56. PubMed ID: 23358983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empirical meropenem versus piperacillin/tazobactam for adult patients with sepsis (EMPRESS) trial: Protocol.
    Granholm A; Munch MW; Meier N; Sjövall F; Helleberg M; Hertz FB; Kaas-Hansen BS; Thorsen-Meyer HC; Andersen LW; Rasmussen BS; Andersen JS; Albertsen TL; Kjær MN; Jensen AKG; Lange T; Perner A; Møller MH
    Acta Anaesthesiol Scand; 2024 Sep; 68(8):1107-1119. PubMed ID: 38769040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.
    Vidal L; Paul M; Ben-Dor I; Pokroy E; Soares-Weiser K; Leibovici L
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003992. PubMed ID: 15495074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral versus intravenous antibiotics for patients with Klebsiella pneumoniae liver abscess: study protocol for a randomized controlled trial.
    Molton J; Phillips R; Gandhi M; Yoong J; Lye D; Tan TT; Fisher D; Archuleta S
    Trials; 2013 Oct; 14():364. PubMed ID: 24176222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two versus five days of antibiotics after appendectomy for complex acute appendicitis (APPIC): study protocol for a randomized controlled trial.
    van den Boom AL; de Wijkerslooth EML; van Rosmalen J; Beverdam FH; Boerma EG; Boermeester MA; Bosmans JWAM; Burghgraef TA; Consten ECJ; Dawson I; Dekker JWT; Emous M; van Geloven AAW; Go PMNYH; Heijnen LA; Huisman SA; Jean Pierre D; de Jonge J; Kloeze JH; Koopmanschap MA; Langeveld HR; Luyer MDP; Melles DC; Mouton JW; van der Ploeg APT; Poelmann FB; Ponten JEH; van Rossem CC; Schreurs WH; Shapiro J; Steenvoorde P; Toorenvliet BR; Verhelst J; Versteegh HP; Wijnen RMH; Wijnhoven BPL
    Trials; 2018 May; 19(1):263. PubMed ID: 29720238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAIN study: a protocol for a randomised controlled trial evaluating efficacy, safety and cost-effectiveness of intravenous-to-oral antibiotic switch therapy in neonates with a probable bacterial infection.
    Keij FM; Kornelisse RF; Hartwig NG; Mauff K; Poley MJ; Allegaert K; Reiss IKM; Tramper-Stranders GA
    BMJ Open; 2019 Jul; 9(7):e026688. PubMed ID: 31289068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial.
    Hagel S; Fiedler S; Hohn A; Brinkmann A; Frey OR; Hoyer H; Schlattmann P; Kiehntopf M; Roberts JA; Pletz MW;
    Trials; 2019 Jun; 20(1):330. PubMed ID: 31171029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT.
    Langton Hewer SC; Smyth AR; Brown M; Jones AP; Hickey H; Kenna D; Ashby D; Thompson A; Sutton L; Clayton D; Arch B; Tanajewski Ł; Berdunov V; Williamson PR
    Health Technol Assess; 2021 Nov; 25(65):1-128. PubMed ID: 34806975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of oral versus intravenous antibiotics in low-risk febrile neutropenic patients with lung cancer.
    Niho S; Ohe Y; Goto K; Ohmatsu H; Matsumoto T; Kubota K; Kakinuma R; Nishiwaki Y
    Jpn J Clin Oncol; 2004 Feb; 34(2):69-73. PubMed ID: 15067098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.